TNF and atrial fibrillation: Transgenic mice with cardiomyocyte-specific TNF-α overexpression exhibit impaired atrial contractility and increased AF susceptibility [93], while TNF-α blockade reduces adverse atrial remodeling in experimental HF models [94].